Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
6-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.5.2
advertisement
11.5.2 Topical
(11)
Showing records 1 to 11
Display all abstracts in classification
11.5.2 Topical
Search within classification 11.5.2 Topical
10317
Effects of topical administration of 1% brinzolamide on normal cat eyes
Gray HE; Willis AM; Morgan RV
Veterinary Ophthalmology
2003; 6: 285-290
10126
Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination
Tsukamoto H; Larsson LI
Archives of Ophthalmology
2004; 122: 190-193
10122
Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
Whitson JT; Henry C; Hughes B; Lee DA; Terry S; Fechtner RD
Journal of Glaucoma
2004; 13: 168-173
10138
Optic nerve oxygen tension: the effects of timolol and dorzolamide
Kiilgaard JF; Pedersen DB; Eysteinsson T; la Cour M; Bang K; Jensen PK; Stefansson E
British Journal of Ophthalmology
2004; 88: 276-279
10523
Binding affinity of bunazosin, dorzolamide, and timolol to synthetic melanin
Kiuchi Y; Terakawa N; Nakata T; Yamasaki K; Saito Y; Ito N; Okada K
Japanese Journal of Ophthalmology
2004; 48: 34-6
10151
Safety comparison of topical brinzolamide 1% and timolol 0.5% in patients with asthma or chronic obstructive pulmonary disease
Friren B; Michaud JE; Mayolle C
Today's Therapeutic Trends
2004; 22: 69-80
10158
Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries
Josefsson A; Sigurdsson SB; Bang K; Eysteinsson T
Experimental Eye Research
2004; 78: 215-221
10157
Effects of brinzolamide on ocular haemodynamics in healthy volunteers
Kaup M; Plange N; Niegel M; Remky A; Arend O
British Journal of Ophthalmology
2004; 88: 257-262
10153
Hypotensive effect and subjective symptoms after substitution of 1% dorzolamide by 1% brinzolamide
Kobayashi H; Kobayashi K; Okinami S
Japanese Journal of Clinical Ophthalmology
2004; 58: 205-209
10154
The efficacy and safety of dose escalation of dorzolamide used in combination with other topical antiglaucoma agents
Araie M; Kitazawa Y; Azuma I; Shirato S; Hamanaka T; Tomita G; Origasa H
Journal of Ocular Pharmacology and Therapeutics
2003; 19: 517-525
10152
Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-α-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits
Winum JY; Casini A; Mincione F; Starnotti M; Montero JL; Scozzafava A; Supuran CT
Bioorganic and Medicinal Chemistry Letters
2004; 14: 225-229
Issue
6-1
Table of Contents
Editor's Selection
Change Issue
24-3 (2024)
24-1/2 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement